Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1, NEJM 2021) Jastreboff AM et al
Both drugs increased incidence of gastrointestinal adverse events compared with placebo, while neither tirzepatide nor semaglutide increased the risk of serious adverse events or severe hypoglycaemia
At 68 weeks, the 12mg group achieved an average weight loss of 28.7%, which translates to an average of 71.2 pounds lost
Bessesen, MD, is an endocrinologist in Denver, Colorado who is affiliated with multiple area hospitals including UCHealth University of Colorado Hospital and Denver Health
Our therapist-led support group provides a safe, supportive space where participants can explore the emotional, psychological, and behavioral roots of their relationship with food while building lasting skills that extend beyond medication
Diuretics (water tablets, often for blood pressure) increase fluid loss, the last thing you want in the heat
